Abstract
Mammalian artificial chromosomes (MACs) are engineered chromosomes with defined genetic content that can function as non-integrating vectors with large carrying capacity and stability. The large carrying capacity allows the engineering of MACs with multiple copies of the same transgene, gene complexes, and to include regulatory elements necessary for the regulated expression of transgene(s). In recent years, different approaches have been explored to generate MACs (Vos Curr Opin Genet Dev 8:351–359, 1998; Danielle et al. Trends Biotech 23:573–583, 2005; Duncan and Hadlaczky Curr Opin Biotech 18:420–424, 2007): (1) the de novo formation by centromere seeding, the “bottom-up” approach, (2) the truncation of natural chromosomes or the modification of naturally occurring minichromosomes, the “top-down” approach, and (3) the in vivo “inductive” approach. Satellite DNA-based artificial chromosomes (SATACs) generated by the in vivo “inductive” method have the potential to become an efficient tool in diverse gene technology applications such as cellular protein manufacturing (Kennard et al. BioPharm Int 20:52–59, 2007; Kennard et al. Biotechnol Bioeng 104:526–539, 2009; Kennard et al. Biotechnol Bioeng 104:540–553, 2009), transgenic animal production (Telenius et al. Chromosome Res 7:3–7, 1999; Co et al. Chromosome Res 8:183–191, 2000; Monteith et al. Methods Mol Biol 240:227–242, 2003), and ultimately a safe vector for gene therapy (Vanderbyl et al. Stem Cells 22:324–333, 2004; Vanderbyl et al. Exp Hematol 33:1470–1476, 2005; Katona et al. Cell. Mol. Life Sci 65:3830–3838, 2008). A detailed protocol for the de novo generation of satellite DNA-based artificial chromosomes (SATACs) via induced large-scale amplification is presented.
Key words
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Vos J-MH (1998) Mammalian artificial chromosomes as tools for gene therapy. Curr Opin Genet Dev 8, 351–359.
Danielle V. Irvine, Margaret L. Shaw, K. H. Andy Choo and Richard Saffery (2005). Engineering chromosomes for delivery of therapeutic genes. Trends Biotech. 23, (12) 573–583.
Duncan, A., Hadlaczky, Gy. (2007). Chromosomal Engineering. Curr Opin Biotech 18, 420–424.
Kennard M.L, Goosney D.G, Ledebur H.C. 2007. Generating stable, high–expressing cell lines for recombinant protein manufacture. BioPharm Int 20, (3):52–59.
Kennard, M.L., Goosney, D.L., Monteith, D., Roe, S., Fischer, D., Mott, J. (2009). Auditioning of CHO host cell lines using the Artificial Chromosome Expression (ACE) technology. Biotechnology and Bioengineering 104(3), 526–539.
Kennard, M.L., Goosney, D.L., Monteith, D., Zhang, L., Moffat, M., Fischer, D., Mott, J. (2009). The generation of stable, high MAb expressing CHO cell lines based on the Artificial Chromosome Expression (ACE) technology. Biotechnology and Bioengineering 104(3), 540–553.
Telenius, H., Szeles, A., Kereső, J., Csonka, E., Praznovszky, T., Imreh, S., Maxwell, A., Perez, C.F., Drayer, J.I., Hadlaczky, Gy. (1999). Stability of a functional murine satellite DNA-based artificial chromosome across mammalian species. Chromosome Res. 7, 3–7.
Co, D.O., Borowski, A.H., Leung, J.D., van der Kaa, J., Hengst, S., Platenburg, G., Pieper, F.R., Perez, C.F., Jirik, F.R., Drayer, J.I. (2000). Generation of transgenic mice and germline transmission of a mammalian artificial chromosome introduced into embryos by pronuclear microinjection. Chromosome Res. 8, 183–191.
Monteith, D.P., Leung, J.D., Borowski, A.H., Co, D.O., Praznovski, T., Jiric, F.R., Hadlaczky, Gy., and Perez, C.F. (2003). Pronuclear microinjection of purified artificial chromosomes for generation of transgenic mice: Pick-and-Inject Technique. In Mammalian Artificial Chromosomes: Methods and Protocols. Eds.: Sgaramella, V. and Eridani, S. Methods in Mol. Biol. 240, 227–242
S. Vanderbyl, G. N. MacDonald, S. Sidhu, L. Gung, A. Telenius, C. Perez, E. Perkins (2004). Transfer and stable transgene expression of a mammalian artificial chromosome into bone marrow-derived human mesenchymal stem cells. Stem Cells. 22, 324–333.
Vanderbyl SL, Sullenbarger B, White N, Perez CF, MacDonald GN, Stodola T, Bunnell BA, Ledebur HC Jr, Lasky LC. (2005). Transgene expression after stable transfer of a mammalian artificial chromosome into human hematopoietic cells. Exp Hematol. 33(12), 1470–1476.
R. L. Katona, I. Sinkó, G. Holló, K. Székely Szűcs, T. Praznovszky, J. Kereső, E. Csonka, K. Fodor, I. Cserpán, B. Szakál, P. Blazsó, A. Udvardy and G. Hadlaczky (2008). A combined artificial chromosome-stem cell therapy method in a model experiment aimed at the treatment of Krabbe`s disease in the Twitcher mouse. Cell. Mol. Life Sci. 65, 3830–3838.
Hadlaczky, Gy., Praznovszky, T., Cserpán, I., Kereső, J., Péterfy, M., Kelemen, I., Atalay, E., Szeles, A., Szelei, J., Tubak, V. (1991). Centromere formation in mouse cells cotransformed with human DNA and a dominant marker gene. Proc. Natl. Acad. Sci. USA. 88, 8106–8110.
Praznovszky, T. Kereső, J. Tubak, V., Cserpán, I., Fátyol, K., Hadlaczky, Gy. (1991). De novo chromosome formation in rodent cells. Proc. Natl. Acad. Sci. USA. 88, 11042–11046.
Kereső, J., Praznovszky, T., Cserpán, I., Fodor, K., Katona, R., Csonka, E., Fátyol, K., Holló, Gy., Szeles, A., Ross, A.R., Sumner, A.T., Szalay, A.A., Hadlaczky, Gy. (1996). De novo chromosome formations by large-scale amplification of the centromeric region of mouse chromosomes. Chromosome Res. 4, 226–239.
Holló, Gy., Kereső, J., Praznovszky, T., Cserpán, I., Fodor, K., Katona, R., Csonka, E., Fátyol, K., Szeles, A., Szalay, A.A., Hadlaczky, Gy. (1996). Evidence for a megareplicon covering megabases of centromeric chromosome segments. Chromosome Res. 4, 240–247.
Csonka, E., Cserpán, I., Fodor, K., Holló, Gy., Katona, R., Kereső, J., Praznovszky, T., Szakál, B., Telenius, A., deJong, G., Udvardy, A., Hadlaczky, Gy. (2000). Novel Generation of Human Satellite DNA-based Artificial Chromosomes in Mammalian Cells. J Cell Sci. 113, 3207–3216.
Hadlaczky, Gy. (2001) Satellite DNA-based artificial chromosomes for use in gene therapy. Current Opinion in Molecular Therapeutics 3(2), 125–132.
Chen, C, Okayama, H. (1987). High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745–2752.
Macgregor, H., Varley, J. (1983) Mitotic chromosomes. Working with animal chromosomes. John Wiley & Sons Ltd.
Lindenbaum, M., Perkins, E., Csonka, E., Greene, A., Fleming, E., Hadlaczky, Gy., MacDonald, N., Maxwell, A., Perez, C. and Ledebur, H.C. Jr. (2004). The ACE System: engineering artificial chromosomes to rapidly generate high-expressing cell lines for manufacture of recombinant proteins. Nucl. Acids Res. 32(21), e172.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Csonka, E. (2011). De Novo Generation of Satellite DNA-Based Artificial Chromosomes by Induced Large-Scale Amplification. In: Hadlaczky, G. (eds) Mammalian Chromosome Engineering. Methods in Molecular Biology, vol 738. Humana Press. https://doi.org/10.1007/978-1-61779-099-7_8
Download citation
DOI: https://doi.org/10.1007/978-1-61779-099-7_8
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-098-0
Online ISBN: 978-1-61779-099-7
eBook Packages: Springer Protocols